Chromium is a trace metal of importance in human physiology and, in addition, as 51-chromate, has been extensively used as a label in the study of blood cell pool sizes and intravascular kinetics. The transport characteristics of 51-chromate were investigated in normal human leukocytes. Chromate uptake is unidirectional over a 1 hr incubation with extracellular chromate concentrations up to 200 µmoles/liter. Under these conditions, intracellular 51-chromium is in a form in which it is nonexchangeable. Influx is temperature sensitive with a Q 10 of approximately 2 and may be energy dependent since a variety of metabolic poisons strongly inhibit uptake. The unidirectional influx of chromate follows Michaelis-Menten kinetics; the maximum velocity is 52 mµmoles/g dry weight of cells per min and the chromate concentration at which influx velocity is half maximal is 87 µmoles/liter. This transport mechanism is highly specific for chromate; other divalent tetrahedral anions only slightly inhibit influx at concentrations up to 10 times that of chromate. Metavanadate, however, competitively inhibits chromate influx at equimolar concentrations. Exposure of cells to unlabeled chromate leads to inhibition of subsequent influx of 51-chromate. It is suggested that this is due to a primary inhibitory effect of chromate on cellular energy metabolism. has been extensively used as a label in the study of blood cell pool sizes and intravascular kinetics. The transport characteristics of 51-chromate were investigated in normal human leukocytes. Chromate uptake is unidirectional over a 1 hr incubation with extracellular chromate concentrations up to 200 omoles/liter. Under these conditions, intracellular 51-chromium is in a form in which it is nonexchangeable. Influx is temperature sensitive with a Qio of approximately 2 and may be energy dependent since a variety of metabolic poisons strongly inhibit uptake. The unidirectional influx of chromate follows Michaelis-Menten kinetics; the maximum velocity is 52 m/moles/g dry weight of cells per min and the chromate concentration at which influx velocity is half maximal is 87 /Lmoles/liter. This transport mechanism is highly specific for chromate; other divalent tetrahedral anions only slightly inhibit influx at concentrations up to 10 times that of chromate. Metavanadate, however, competitively inhibits chromate influx at equimolar concentrations. Exposure of cells to unlabeled chromate leads to inhibition of subsequent influx of 51-chromate. It is suggested that this is due to a primary inhibitory effect of chromate on cellular energy metabolism.
INTRODUCTION
Radioactive chromium as sodium 51-chromate has been extensively used as a cell label since 1950 when Gray and Sterling (1) first reported its ability to bind to erythrocytes and utilized this interaction for estimation of red cell mass. It was subsequently applied to studies of red cell intravascular kinetics (2) and has, in addition, been used to label tumor cells (3) , platelets (4) , and leukocytes (5) in similar types of studies. Apart from the importance of chromium in this regard, there is considerable evidence that it is an essential trace mineral in human physiology (6) . Thus, an understanding of the mechanism by which chromium is transported across the cell membrane is of interest. As a part of investigations utilizing 51-chromate as a cell label, numerous attempts to define optimal labeling conditions have been made but there has been no systemic study of chromate uptake by cells. The present investigation was undertaken in an attempt to characterize in detail the mechanism by which chromate is taken up by human leukocytes.
METHODS
Cells. Normal human leukocytes were separated from citrated whole blood by centrifugation at 1500 g for 3 min.
To remove residual erythrocytes, the buffy coat was diluted 1:1 with 0.9% NaCl and sedimented through a column of 3% dextran (average molecular weight of 280,000) followed by two 30-sec periods of hypotonic lysis. The cells were washed in the incubation medium described below and then counted with an electronic counter (Model B, Coulter Electronics Inc., Hialeah, Fla.). All 
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Analytical methods. Samples consisting of from 5 to 10 X 107 cells were obtained at appropriate times and immediately added to 10 volumes of 0.9% NaCl at 0C. After centrifugation at 2000 g for 30 sec, the supernate was removed and discarded. The cells were then washed twice with 10-ml aliquots of 0.9% NaCl at 00C by vigorous resuspension of the cell button followed by centrifugation as above. More than two washes did not result in the removal of additional 51-chromium from the cell fraction. The final supernate was removed as completely as possible and the cell button aspirated into the tip of a Pasteur pipet, transferred to preweighed glassine discs, and dried overnight at 650C. The dried cells on their glassine tares were then weighed and transferred to counting tubes. Dry weights varied from 3 to 6 mg. All weighings were done on a Cahn Electrobalance (Model RG, Cahn Instrument Co., Paramount, Calif.). Radioactivity was determined in a well-type scintillation counter (Nuclear-Chicago, Des Plaines, Ill.) with counting for a time sufficient to give a counting error of less than ±+1.4%,. Chromate uptake (as 51-chromium) was computed in millimicromoles per gram dry weight of cells, and velocity is expressed as uptake per minute. The results of a typical single experiment are shown in Fig. 3 . The linearity of the double reciprocal plot with a positive ordinate intercept suggests that chromate influx is compatible with Michaelis-Menten kinetics. In 12 experiments, the maximum influx velocity (V.a.) was 51.9 ±9.6 mnmoles/g dry wt per min, and the chromate concentration at which influx velocity was i Vmax (Kt) was 87.1 ± 11.7 imoles/liter.
Since the chromate concentrations are so much higher than reported normal human blood chromium values of from 0.5 to 1.0 moles/liter (6), we were concerned that a higher-affinity, lower-capacity transport system might have been overlooked. That such a mechanism could be significant is unlikely since chromate influx velocity is a linear function of the extracellular chromate concentration over a range of from 0.1 to 8 Moles/ liter (Fig. 4) and the intercept of this plot passes through the origin. FIGURE 4 The relationship between low extracellular chromate concentrations and unidirectional influx velocity. Influx was measured as described in the text and the legend in In these experiments, the magnitude of the rapid uptake component was found to be proportional to the extracellular chromate concentration up to a level of at least 150 ,moles/liters.
Effect of various anions on chromate influx. All anions studied caused significant inhibition of chromate influx velocity (Table I) influx is seen in Fig. 5 . In the presence of metavanadate the slope of the reciprocal plot is increased while the ordinate intercept is unchanged, indicating competitive inhibition.
Results with phosphate-free buffer indicate that 1.1 mM phosphate present in the usual medium does not inhibit chromate influx; on the contrary, the presence of phosphate appears to cause a small (6.8%) but significant rise in chromate influx possibly due to an enhancement of energy metabolism (see below).
Effect of metabolic inhibitors on chromate influx.
The effects of a variety of metabolic inhibitors on chromate transport are listed in Table II . All caused significant depression of chromate influx. Again, the time course of uptake in the presence of these inhibitors remained linear. Inhibition by 2,4-dinitrophenol was reversed by the addition of glucose, while glucose alone did not alter chromate influx. From other experiments, 0.1 mm sodium p-chloromercuribenzene sulfonate inhibited chromate influx by 57.3%
The effect of iodoacetate and 2-deoxyglucose on the kinetics of chromate influx was studied. In four experiments, both inhibitors caused depression of the influx VmaX with a smaller rise in the influx Kt. A typical experiment is shown in Fig. 6 . Although these kinetic alterations were not quantitatively prominent, they were seen in all experiments.
Self-inhibition of chromate influx by chromate. To investigate the possibility of a carrier mechanism for Table I ). In these experiments no significant effect was found with any of the compounds studied. (Fig. 8) Fig. 6 . DISCUSSION These studies establish the existence of a transport mechanism for chromate ion in the human leukocyte. Chromate influx follows Michaelis-Menten kinetics and the influx Qio is compatible with a mediated process. This mechanism is highly specific since related anions only weakly inhibit chromate influx even at very high concentrations. Only metavanadate inhibited chromate influx at equimolar concentrations and the kinetics of this inhibition were competitive.
Evidence that chromate transport is uphill against an electrochemical-potential gradient was not obtainable since conditions were never achieved under which significant free intracellular chromate could be demonstrated. However, the data suggests that the transport process may be energy dependent since influx was inhibited by a variety of metabolic poisons. In the absence of exchangeable intracellular chromate, it was also difficult to test for a possible carrier mechanism by exchange phenomena. While the unidirectional influx of chromate into cells preincubated with metavanadate was unchanged, the degree to which metavanadate enters the cell, if at all, and its intracellular fate are not known.
These studies indicate that the intracellular disposition for chromate involves reaction(s) that render it incapable of readily leaving the cell or of exchanging with extracellular unlabeled chromate. Because free intracellular chromate does not accumulate, these reaction(s) must proceed as fast as chromate enters the cell and thus the influx process is unidirectional, uptake is linear with time, and influx is the rate-limiting step in the association of 51-chromate with these cells. In addition, since this linear relationship is maintained under a number of inhibitory conditions such as in the presence of metabolic poisons or metavanadate, or after exposure to unlabeled chromate, these inhibitory effects must be due to a direct effect on the transport process itself or its energetics rather than to an effect on the intracellular disposition of chromate.
The lack of exchangeable intracellular chromate in this study is compatible with other reported data. Most intracellular chromium in erythrocytes incubated with 51-chromate is protein bound, largely to the P-chain of the globin moiety of hemoglobin (8) . There is evidence that hexavalent chromate (Cr VI) is reduced to the trivalent state (Cr III) before, or during the binding to hemoglobin (9) , and after uptake into Ehrlich ascites cells (10) and leukocytes (11) . Cr III does not exist in biological systems in a simple cationic form but rather as coordination compounds with substituent groups of low molecular weight compounds, such as glutathione, or larger molecules, such as proteins (6, 12) . These chromium coordination compounds have a slow rate of ligand exchange and the complexes are quite stable (6) .
The inhibitory effect of chromate preincubation on subsequent 51-chromate influx is interpreted as reflecting a primary inhibition of energy metabolism by chromate which in turn affects the energy-dependent transport of that ion. In the absence of exchangeable intracellular chromate, this cannot be related to an exchange phenomenon. The rapidity of onset of the chromate "autoinhibition," the observation that uptake is linear with time, and the dependence of the inhibitory effect on extracellular chromate concentration rather than on the total amount of chromium within the cell suggests that this action of chromate on the metabolic apparatus is at sites on or near to the cell surface. This would be consistent with an effect on the site of energy coupling with transport but the lack of a suitable model for chromate transport does not allow for precise localization.
The mechanism of chromate "autoinhibition" is likely related to the ability of chromate to inhibit energy metabolism. Thus 200 uM chromate inhibits red blood cell oxygen consumption (13) (14) and has been isolated in erythrocyte fractions which contain a number of other important enzymes including glucose-6-phosphate dehydrogenase (12) .
Although the measured portion of the time course of chromate uptake is linear, there is an early rapid uptake component which occurs instantaneously and persists at 0°C. This probably represents a surface adsorption of 51-chromium to the cell membrane. It is also possible that this component represents a burst of chromate influx before autoinhibition becomes significant. To account for this, however, the uninhibited rate would have to be far greater than seems likely with the degree of inhibition observed. In addition, the early rapid component was present even at extracellular chromate levels which did not cause significant "autoinhibition."
Because exchangeable intracellular chromate was not demonstrated in these studies, the question may be raised that all the phenomena observed are related to chromate binding to sites on or near the cell surface rather than to a transmembrane flux. We exclude this possibility for the following reasons: (a) over the extracellular chromate concentration range studied, the rate of chromate uptake is constant with time and thus independent of the total amount of chromate associated with the cells. However, the influx rates are a hyperbolic function of the extracellular chromate level. If the uptake kinetics were related to saturation of surface-binding sites, the rate of uptake at high chromate concentrations should fall with time as the number of available binding sites are reduced. (b) A dependence on energy metabolism would be unique for a surface binding; (c) surface binding might be expected to be exothermic while chromate uptake is clearly increased with a rise in temperature; and (d) other studies discussed above suggest that chromate enters the intracellular compartment of a number of cell types and participates in intracellular reactions.
It is likely that chromium is an essential trace element in human physiology; this has recently been reviewed extensively (6) . Although chromium is absorbed from the gut as Cr VI, it appears to be present in blood as Cr III which is considered to be the biologically active state. However, a number of mammalian tissues, including erythrocytes (15) and intestine (16) , are impermeable to this ion. This suggests that an important intracellular role for chromium would require that chromium be present in the blood in a form which can readily traverse cellular membranes. The presence of a highly specific transport mechanism for Cr VI in human leukocytes suggests that Cr VI may be the form in which chromium penetrates the cell membrane and thus Cr VI may have an important physiological function. It is possible that the sensitivities of current methods for the detection of trace amounts of Cr VI in the blood are inadequate.
